SeaStar Medical is trading 5.2% down at $2.97 despite broad U.S. market gains on September 11, 2026; the reason remains unclear.

  • The HC Wainwright conference presentation became available at 7:00 a.m. EDT.
  • No earnings, FDA decision, financing, guidance change, or other clearly negative company-specific catalyst was identified.